Pfizer, Inc. (PFE) CEO Albert Bourla on Q1 2022 Results - Earnings Call Transcript

Pfizer, Inc. (NYSE:NYSE:PFE) Q1 2022 Earnings Conference Call May 03, 2022, 10:00 ET Company Participants Christopher Stevo - SVP & Chief IR Officer Albert Bourla - Chairman & CEO...

Related Keywords

United States ,Israel ,Italy ,China ,Russia ,Quebec ,Canada ,Ukraine ,Italian ,Russian ,Russians ,Robyn Karnauskas ,Frank Damelio ,Andrew Baum ,Albert Bourla ,Tim Anderson ,Chris Stevo ,Evan Seigerman ,Carter Gould ,William Pao ,David Denton ,Angela Hwang ,Terence Flynn ,Doug Lankler ,Kerry Holford ,Geoff Meacham ,Alex Hammond ,Steve Scala ,America Merrill Lynch ,Christopher Schott ,Aamir Malik ,Christopher Stevo ,Mikael Dolsten ,Louise Chen ,Chris Schott ,Stephen Scala ,Timothy Anderson ,Colin Bristow ,Mohit Bansal ,Morgan Stanley ,Development Officer ,Company Participants ,Pfizer ,Worldwide Research ,Jpmorgan Chase Co ,Biopharmaceuticals Group ,Pfizer Inc ,Wolfe Research ,Barclays ,Wells Fargo ,Barclays Bank ,Cantor Fitzgerald Co ,Patient Assistance Program ,National Panoramic Study ,Pfizer Biopharmaceuticals Group ,Citigroup ,Conference Call May ,Scientific Officer ,America Merrill ,First Quarter ,Senior Vice President ,Chief Investor Relations ,Frankd Amelio ,Group President ,Chief Business ,Innovation Officer ,General Counsel ,Chief Development ,Investor Relations ,Risk Factors ,Emergency Use Authorization ,Conditional Market Authorization ,While Pfizer ,Executive Vice President ,Chief Financial Officer ,Executive Vice ,Annual Pharmaceutical Innovation ,Invention Index ,Total Rd Productivity ,New Drug Application ,Vitiligo Area Severity Indexes ,Fast Track Designation ,European Medicines Agency ,Medicinal Products ,Human Use ,Prime Designation ,Vamil Divan ,Patient Assistance ,Latin America ,